Investigational Drug Details
| Drug ID: | D526 |
| Drug Name: | DUR-928 |
| Synonyms: | 25HC3S; DUR-928; DUR-928 sodium - DURECT Corporation; DV-928; Larsucosterol sodium - DURECT Corporation |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | DNA methylation inhibitors; Inflammation mediator modulators; Lipid modulators |
| Therapeutic Category: | Anti-inflammatories; Antipsoriatics; Hepatoprotectants |
| Clinical Trial Progress: | Phase 1 on-going (ACTRN12615001355561) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0598 | ACTRN12615001355561 | Phase 1 | Not Recruiting | No Results Available | 14/12/2015 | 13 January 2020 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|